Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Journal of Biopharmaceutical Statistics|March 1, 1997
Common noncompartmental pharmacokinetic variables: are they normally or log-normally distributed?L F Lacey, O N Keene, J F Pritchard, et al.Journal of Pharmaceutical and Biomedical Analysis|March 7, 2000
In vitro metabolic products of RWJ-34130, an antiarrythmic agent, in rat liver preparationsW N Wu, L A McKown, K A Yorgey, et al.Journal of Applied Toxicology : JAT|June 1, 1984
Alterations of drug-induced toxicity in the mouse lymphoma assay by a rat hepatic microsomal metabolizing system (S-9)J W Oldham, R F Preston, J D Paulson, et al.Teratogenesis, Carcinogenesis, and Mutagenesis|January 1, 1988
Teratogenicity of N-(4-hydroxyphenyl)-all-trans-retinamide in rats and rabbitsM F Kenel, J H Krayer, E A Merz, et al.Clinical Pharmacology and Therapeutics|November 1, 1983
Influence of uremia, hemodialysis, and nonesterified fatty acids on zomepirac plasma protein bindingJ F Pritchard, P J O'Neill, M B Affrime, et al.Journal of Clinical Pharmacology|July 1, 1985
Plasma protein binding of bepridilJ F Pritchard, L A McKown, B H Dvorchik, et al.Journal of Pharmaceutical Sciences|September 1, 1986
Evaluation of drug absorption and presystemic metabolism using an in situ intestinal preparationK A Yorgey, J F Pritchard, N L Renzi, et al.Pharmacology|January 1, 1984
Influence of uremia and hemodialysis on the plasma protein binding of tolmetinJ F Pritchard, P J O'Neill, M B Affrime, et al.Journal of Pharmaceutical Sciences|July 1, 1994
Ondansetron absorption in adults: effect of dosage form, food, and antacidsH P Bozigian, J F Pritchard, A E Gooding, et al.Clinical Biochemistry|June 1, 1978
The contribution of propranolol metabolites to the fluorometric assay of propranolol in human plasmaJ F Pritchard, D W Schneck, W J Racz, et al.Pageof 4